Compare PCRX & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | SAFE |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.0M | 1.1B |
| IPO Year | 2010 | 1999 |
| Metric | PCRX | SAFE |
|---|---|---|
| Price | $25.17 | $16.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 10 |
| Target Price | ★ $30.25 | $19.00 |
| AVG Volume (30 Days) | ★ 450.1K | 374.4K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.48% |
| EPS Growth | ★ 107.44 | 7.43 |
| EPS | 0.07 | ★ 0.40 |
| Revenue | ★ $541,533,000.00 | $385,552,000.00 |
| Revenue This Year | $6.78 | N/A |
| Revenue Next Year | $8.54 | $4.31 |
| P/E Ratio | $364.29 | ★ $40.80 |
| Revenue Growth | ★ 26.04 | 5.43 |
| 52 Week Low | $18.80 | $12.76 |
| 52 Week High | $27.64 | $17.16 |
| Indicator | PCRX | SAFE |
|---|---|---|
| Relative Strength Index (RSI) | 60.53 | 54.98 |
| Support Level | $22.03 | $14.71 |
| Resistance Level | $27.03 | $16.39 |
| Average True Range (ATR) | 0.94 | 0.43 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 69.42 | 67.26 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.